Related Experiment Video
Updated: Jul 14, 2026

Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein
Published on: June 30, 2019
Curriculum Vitae of WEE2 Kinase in Homeostasis and Diseases: A Systematic Review
Ran Wang1,2,3, Jing Yu1,2,3, Yan-Jun Liu1,2,3
1State Key Laboratory for Quality and Safety of Agro-Products, School of Marine Sciences, Ningbo University, Ningbo 315211, China.
Abstract:
WEE2, an oocyte-specific kinase of the WEE family, is a core regulator of oocyte meiosis. It maintains germinal vesicle (GV) arrest and prevents premature meiotic resumption by phosphorylating cyclin-dependent kinase 1 (CDK1), thereby inhibiting maturation-promoting factor (MPF) activity. WEE2 also regulates exit from metaphase II (MII), ensuring orderly meiotic progression. Consequently, the functional integrity of WEE2 is essential for female reproduction. Homozygous or compound heterozygous mutations in the WEE2 gene represent a major genetic cause of total fertilization failure and primary infertility, as these mutations lead to reduced or abolished kinase activity, impair meiotic control, and disrupt oocyte maturation and embryonic development. This review systematically summarizes the protein structure, core functions, and mutation types of WEE2, along with its association with total fertilization failure and female primary infertility. It also highlights research advances in WEE2-targeted inhibitors and discusses the potential applications and future directions of WEE2 in the diagnosis and management of reproductive disorders.
Insights
WEE2 kinase is crucial for female reproduction, maintaining oocyte meiotic arrest. Mutations in WEE2 cause infertility by disrupting oocyte maturation and fertilization.
Area of Science:
- Reproductive Biology
- Molecular Genetics
- Cell Biology
Background:
- WEE2 is an oocyte-specific kinase regulating meiosis.
- It maintains germinal vesicle (GV) arrest and prevents premature meiotic resumption by inhibiting maturation-promoting factor (MPF) activity via cyclin-dependent kinase 1 (CDK1) phosphorylation.
- WEE2 also controls exit from metaphase II (MII), ensuring proper meiotic progression.
Purpose of the Study:
- To systematically review WEE2's structure, functions, and mutations.
- To explore the association between WEE2 gene mutations and total fertilization failure/primary infertility.
- To highlight advances in WEE2-targeted inhibitors and their potential in reproductive disorder management.
Main Methods:
- Systematic literature review.
- Analysis of WEE2 protein structure and kinase functions.
- Review of genetic mutation data and clinical associations with infertility.
Main Results:
- WEE2 mutations impair kinase activity, disrupting meiotic control, oocyte maturation, and embryonic development.
- These mutations are a significant genetic cause of total fertilization failure and primary infertility.
- Research is advancing on WEE2-targeted inhibitors for potential therapeutic applications.
Conclusions:
- The functional integrity of WEE2 is vital for female fertility.
- WEE2 mutations are directly linked to reproductive failure.
- WEE2 presents a potential target for diagnosing and managing female infertility.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
MAPK Signaling Cascades
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Role of ER in the Secretory Pathway
Components of the secretory pathway
About a third of proteins synthesized in the cell are sorted via the secretory route. They shuffle between different compartments in membrane-bound vesicles until they reach their final destination. The main intracellular compartments involved...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...

